Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Exact Sciences Corporation    EXAS

EXACT SCIENCES CORPORATION

(EXAS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization1 7 75513 61621 07020 568--
Entreprise Value (EV)1 7 32014 12021 07021 34421 66521 738
P/E ratio -44,1x-145x-23,6x-35,5x-48,3x-87,0x
Yield ------
Capitalization / Revenue 17,1x15,5x14,1x11,8x9,52x7,97x
EV / Revenue 16,1x16,1x14,1x12,2x10,0x8,42x
EV / EBITDA -52,7x-117x808x-82,3x-182x146x
Price to Book 11,4x5,97x-7,74x9,00x9,53x
Nbr of stocks (in thousands) 122 900147 232159 030169 093--
Reference price (USD) 63,192,5132122122122
Last update 02/21/201902/11/202002/16/202102/17/202102/17/202102/17/2021
1 USD in Million
Estimates
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales1 4548761 4911 7472 1612 582
EBITDA1 -139-12126,1-259-119149
Operating profit (EBIT)1 -159-171-137-470-360-180
Operating Margin -35,1%-19,5%-9,21%-26,9%-16,7%-6,96%
Pre-Tax Profit (EBT)1 -175-269-857-593-421-237
Net income1 -175-84,0-849-586-444-238
Net margin -38,5%-9,59%-56,9%-33,5%-20,5%-9,22%
EPS2 -1,43-0,64-5,61-3,42-2,52-1,40
Dividend per Share2 ------
Last update 02/21/201902/11/202002/16/202102/18/202102/18/202102/18/2021
1 USD in Million
2 USD
Estimates
Balance Sheet Analysis
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt1 -504-7761 0961 170
Net Cash position1 435-----
Leverage (Debt / EBITDA) 3,13x-4,18x--2,99x-9,23x7,85x
Free Cash Flow1 -219-287--204-47,7196
ROE (Net Profit / Equities) -29,2%-5,66%--25,4%-19,6%-6,77%
Shareholders' equity1 6011 484-2 3102 2613 513
ROA (Net Profit / Asset) -16,5%-3,34%--15,9%-10,5%-2,00%
Assets1 1 0612 515-3 6834 22711 898
Book Value Per Share2 5,5315,5-15,713,512,8
Cash Flow per Share2 -0,57-0,88--2,00-0,271,53
Capex1 150172-100108118
Capex / Sales 33,0%19,6%-5,73%4,99%4,57%
Last update 02/21/201902/11/202002/16/202102/23/202102/23/202102/17/2021
1 USD in Million
2 USD
Estimates
Finances - Leverage
Financial data source
© 2021 S&P Global Market Intelligence
Key data
Capitalization (USD)
20 568 492 225
Net sales (USD)
1 491 391 000
Number of employees
4 900
Sales / Employee (USD)
304 366
Free-Float
93,4%
Free-Float capitalization (USD)
19 217 441 854
Avg. Exchange 20 sessions (USD)
233 462 095
Average Daily Capital Traded
1,14%
EPS & Dividend